Triple
T10401936
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | dabigatran |
E245168
|
entity |
| Predicate | hasReversalAgent |
P93715
|
FINISHED |
| Object |
idarucizumab
Idarucizumab is a monoclonal antibody fragment used as a specific antidote to rapidly reverse the anticoagulant effects of dabigatran in cases of emergency or uncontrolled bleeding.
|
E861730
|
NE FINISHED |
Provenance (7 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69d381be340c8190b05998703d42d224 |
elicitation | completed |
| NER | batch_69d4e9e42da08190a5383df3df6d3c18 |
ner | completed |
| NED1 | batch_69d7fbd13c888190b3a79a9aacb5291e |
ned_source_triple | completed |
| NED2 | batch_69d859cc1aac8190ab232bb4e4e4fac1 |
ned_description | completed |
| NEDg | batch_69d822d597088190bf3dca85e1ddb890 |
nedg | completed |
| PD | batch_69d4dfb438c481908dff87c47de2f069 |
pd | completed |
| PDg | batch_69d4e944fac4819093b0312aa0efd729 |
pdg | completed |
Created at: April 6, 2026, 12:08 p.m.